CTM Biomedical, LLC specializes in the development of human placental connective tissue implants designed to augment damaged tissue and support the body's natural healing processes. Their technology focuses on creating immune-privileged Connective Tissue and Extracellular Matrix (ECM) structural implants that serve to cover, protect, and replace inadequate or damaged tissue during surgical procedures. The ECM is composed of various structural and functional components, including collagens, glycoproteins, and growth factors, which collectively form a three-dimensional matrix that provides essential support to the body's tissues and cells. This innovative approach aims to enhance the body's constructive remodeling process, which is crucial for successful tissue repair and recovery.

The products offered by CTM Biomedical are tailored for diverse surgical applications, providing options such as injectables and protective wraps that facilitate tissue augmentation. These implants are designed for homologous use, ensuring they effectively cover or supplement damaged connective tissue. With a five-year shelf life and sterilization through irradiation, the implants are intended for single patient use, emphasizing safety and efficacy in surgical settings. By leveraging the properties of connective tissue, CTM Biomedical aims to address the challenges faced by surgeons in managing tissue damage and improving post-operative outcomes.

United States

CTM is dedicated to developing surgical implants to help physicians treat post-operative biologic issues that are beyond their control.

CTM Biomedical, LLC

Company Details